摘要
目的:探讨辛伐他汀治疗不稳定型心绞痛对其高敏C反应蛋白水平的影响。方法:100例不稳定心绞痛患者被随机分为实验组和对照组,两组均给予常规治疗,实验组加用辛伐他汀治疗。结果:(1)对照组治疗前后TG,TC,LDL-C,HDL-C和hs-CRP等指标有轻微改善,实验组治疗前后有显著统计学差异(P<0.05),实验组和对照组相比也有显著统计学差异(P<0.05)。(2)实验组显效率和总有效率均显著优于对照组(P<0.05)。(3)治疗期间两组均未发生严重副反应。结论:采取辛伐他汀治疗不稳定性心绞痛,能显著控制炎症反应和降低血脂,改善患者生活质量,是值得考虑的治疗方案。
Objective：To explore the clinical influence of Clopidogret on hs-CRP of patients with unstable angina pectoris. Methods： 100 cases of patients with unstable angina pectoris were randomly divided into experimental group and control group. Both groups were given routine treatment, and experimental group was added with therapy of ClopidogrekResutts：（1） The TG.TC.LDL-CoHDL-C and hs-CRP in control group has turned better little before and after therapy, in experimental group has significant change（P〈0.05）;the comparation between two groups also showed significant difference after therapy（P〈0.05）.（2） The excellent rate and total effective rate in experimental group were significantly better than that in control group（P〈0.05）.（3） Both group had no serious side-action happened during therapy period.Conelusion：Clopidogrel used in treatment of unstable angina pectoris.can significantly control inflammatory response and decrease blood-fat,enhance life quality of patients,so it is a desirable treatment method.
出处
《中国医药导刊》
2011年第8期1364-1365,共2页
Chinese Journal of Medicinal Guide
